Angela C Freeland

Title: Angela C. Freeland: Innovator in Blood Analyte Monitoring

Introduction

Angela C. Freeland is a notable inventor based in Austin, TX (US). She has made significant contributions to the field of medical technology, particularly in the area of blood analyte monitoring. Her innovative work focuses on methods for accurately estimating analyte concentrations in bodily fluids, which can have profound implications for patient care and monitoring.

Latest Patents

Angela holds a patent for her invention titled "Blood analyte monitoring through subcutaneous measurement." This patent describes a method for obtaining an estimate of an analyte concentration in a first fluid by utilizing measurements from a second fluid. The process involves minimizing a specific relation to determine the analyte concentration in the first fluid. This method can be particularly useful for determining blood glucose levels from subcutaneous tissue measurements, employing devices such as electrochemical sensors.

Career Highlights

Angela C. Freeland has worked with Therasense, Inc., a company known for its advancements in diabetes management technology. Her role at Therasense has allowed her to contribute to the development of innovative solutions that enhance the quality of life for individuals with diabetes. With her expertise, she has been able to bridge the gap between technology and healthcare.

Collaborations

Angela has collaborated with Roger Bonnecaze, a fellow innovator in the field. Their partnership has fostered the development of cutting-edge technologies that aim to improve health monitoring and patient outcomes.

Conclusion

Angela C. Freeland's contributions to blood analyte monitoring exemplify the impact of innovation in healthcare. Her work not only advances medical technology but also enhances the lives of patients who rely on accurate monitoring for their health management.